Microbix Biosystems Inc. (MBX.TO)
Company Info
Highlights
CA$78.28M
CA$0.03
18.33
CA$16.99M
CA$9.17M
CA$1.77M
CA$0.29 - CA$0.55
CA$0.90
0.25%
0.03
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of CA$10,000 in Microbix Biosystems Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Microbix Biosystems Inc. had a return of 34.15% year-to-date (YTD) and 34.15% in the last 12 months. Over the past 10 years, Microbix Biosystems Inc. had an annualized return of -0.37%, while the S&P 500 had an annualized return of 11.33%, indicating that Microbix Biosystems Inc. did not perform as well as the benchmark.
MBX.TO
34.15%
25.00%
57.14%
34.15%
20.83%
-0.37%
^GSPC (Benchmark)
3.96%
1.97%
10.09%
22.16%
12.70%
11.33%
Monthly Returns
The table below presents the monthly returns of MBX.TO, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 19.51% | 34.15% | |||||||||||
| 2024 | -0.00% | 2.56% | -7.50% | -5.41% | -8.57% | -6.25% | 13.33% | 11.76% | -10.53% | -5.88% | -3.12% | 32.26% | 5.13% |
| 2023 | -9.76% | -2.70% | 5.56% | 2.63% | 2.56% | -2.50% | -17.95% | 3.12% | -6.06% | -12.90% | 11.11% | 30.00% | -4.88% |
| 2022 | -18.07% | -20.59% | 11.11% | -11.67% | 5.66% | -10.71% | -3.00% | 11.34% | -5.56% | -1.96% | -8.00% | -10.87% | -50.60% |
| 2021 | 20.00% | 23.53% | -6.35% | 8.47% | -6.25% | -8.33% | 10.91% | 3.28% | 0.00% | 9.52% | 8.70% | 10.67% | 95.29% |
| 2020 | -2.04% | -16.67% | 20.00% | 37.50% | 3.03% | -4.41% | 0.00% | -18.46% | -1.89% | 44.23% | 6.67% | 6.25% | 73.47% |
| 2019 | 6.38% | 2.00% | -3.92% | 14.29% | 21.43% | -8.82% | -17.74% | -3.92% | -2.04% | 2.08% | -4.08% | 4.26% | 4.26% |
| 2018 | -1.64% | -0.00% | -6.67% | 12.50% | -1.59% | -4.84% | -11.86% | 3.85% | -7.41% | -16.00% | -9.52% | 23.68% | -22.95% |
| 2017 | 17.65% | -6.67% | -14.29% | 2.08% | 32.65% | -6.15% | -9.84% | 27.27% | 5.71% | -8.11% | -1.47% | -8.96% | 19.61% |
| 2016 | -15.63% | -7.41% | 14.00% | -5.26% | -11.11% | -8.33% | 27.27% | -3.57% | -12.96% | -2.13% | -4.35% | 15.91% | -20.31% |
| 2015 | -26.83% | -11.67% | 3.77% | -0.00% | -7.27% | -8.82% | -17.20% | 11.69% | -10.47% | -11.69% | -14.71% | 10.34% | -60.98% |
| 2014 | 203.03% | -5.00% | -20.00% | -0.00% | -3.95% | -4.11% | 25.71% | 4.55% | 30.43% | 13.33% | 22.06% | -1.20% | 396.97% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of MBX.TO is 63, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Microbix Biosystems Inc. (MBX.TO) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the Microbix Biosystems Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Microbix Biosystems Inc. was 92.86%, occurring on Dec 4, 2013. The portfolio has not yet recovered.
The current Microbix Biosystems Inc. drawdown is 68.57%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -92.86% | Mar 7, 2000 | 3180 | Dec 4, 2013 | — | — | — |
| -72.73% | Jan 27, 1993 | 257 | Nov 25, 1994 | 243 | May 7, 1996 | 500 |
| -59.82% | Jun 8, 1999 | 121 | Dec 13, 1999 | 41 | Feb 15, 2000 | 162 |
| -38.19% | Sep 8, 1998 | 52 | Dec 23, 1998 | 85 | May 21, 1999 | 137 |
| -35.68% | Jun 26, 1998 | 39 | Aug 28, 1998 | 3 | Sep 3, 1998 | 42 |
Volatility
Volatility Chart
The current Microbix Biosystems Inc. volatility is 25.40%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Valuation
The Valuation section provides an assessment of the market value of Microbix Biosystems Inc. compared to its peers in the Biotechnology industry.
PE Ratio
The chart displays the price to earnings (P/E) ratio for MBX.TO in comparison to other companies of the Biotechnology industry. Currently, MBX.TO has a PE value of 18.3. This PE ratio falls in the average range for the industry.PEG Ratio
The chart displays the price to earnings to growth (PEG) ratio for MBX.TO in comparison to other companies of the Biotechnology industry. Currently, MBX.TO has a PEG value of 0.0. This PEG ratio is much higher than those of other companies of the industry. This might be an indicator of the company being overvalued.Historical P/E Ratio Chart
The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Microbix Biosystems Inc..
Loading data...
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |